Leborgne Laurent, Cheneau Edouard, Wolfram Roswitha, Pinnow Ellen E, Canos Daniel A, Pichard Augusto D, Suddath William O, Satler Lowell F, Lindsay Joseph, Waksman Ron
Cardiovascular Research Institute, Washington Hospital Center, Washington, DC 20010, USA.
Am J Cardiol. 2004 Feb 15;93(4):389-93. doi: 10.1016/j.amjcard.2003.10.029.
The objectives of this study were to determine whether there are race-based differences in baseline characteristics and in short- or long-term outcomes after percutaneous coronary intervention (PCI). African-Americans have a higher incidence of coronary artery disease but are less likely to undergo coronary revascularization than Caucasians. Little is known about the profiles and outcomes of African-Americans who undergo PCI. Consecutive series of 1,268 African-Americans and 10,561 Caucasians with symptomatic coronary artery disease who underwent PCI between January 1994 and June 2001 were analyzed. Patients hospitalized for acute myocardial infarction were excluded. African-Americans were older, were more likely to be women, and had more co-morbid baseline conditions compared with Caucasians. Preprocedure lesion characteristics were similar with regard to vessel size, length, and complexity. The rate of clinical success did not differ between the groups. African-Americans experienced more in-hospital combined events of death and Q-wave myocardial infarction (p = 0.03). After propensity score adjustment, African-American race was not an independent predictor for in-hospital events. At 1 year, African-Americans had a slightly lower rate of target lesion revascularization and a 50% higher rate of death (9.8% vs. 6.4%, p <0.001), with a relative risk of 1.52 (95% confidence interval 1.22 to 1.89). In multivariate analysis, African-American race remained a significant predictor of increased 1-year mortality (hazard ratio 1.35, 95% confidence interval 1.06 to 1.71, p = 0.01). African-Americans undergoing angioplasty have more co-morbid baseline conditions than Caucasians. Despite similar clinical success, 1-year outcomes are impaired in African-Americans.
本研究的目的是确定经皮冠状动脉介入治疗(PCI)后,基线特征以及短期或长期预后是否存在基于种族的差异。非裔美国人冠心病发病率较高,但与白种人相比,接受冠状动脉血运重建的可能性较小。对于接受PCI的非裔美国人的情况和预后了解甚少。分析了1994年1月至2001年6月期间连续接受PCI的1268例有症状冠心病的非裔美国人和10561例白种人。排除因急性心肌梗死住院的患者。与白种人相比,非裔美国人年龄更大,女性比例更高,基线合并症更多。术前病变特征在血管大小、长度和复杂性方面相似。两组临床成功率无差异。非裔美国人住院期间死亡和Q波心肌梗死的合并事件更多(p = 0.03)。经过倾向评分调整后,非裔美国人种族不是住院事件的独立预测因素。在1年时,非裔美国人的靶病变血运重建率略低,死亡率高50%(9.8%对6.4%,p <0.001),相对风险为1.52(95%置信区间1.22至1.89)。在多变量分析中,非裔美国人种族仍然是1年死亡率增加的显著预测因素(风险比1.35,95%置信区间1.06至1.71,p = 0.01)。接受血管成形术的非裔美国人比白种人有更多的基线合并症。尽管临床成功率相似,但非裔美国人的1年预后较差。